175 related articles for article (PubMed ID: 21748247)
1. Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.
Pommier SJ; Hernandez A; Han E; Massimino K; Muller P; Diggs B; Chamberlain E; Murphy J; Hansen J; Naik A; Vetto J; Pommier RF
Ann Surg Oncol; 2012 Feb; 19(2):527-35. PubMed ID: 21748247
[TBL] [Abstract][Full Text] [Related]
2. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919
[TBL] [Abstract][Full Text] [Related]
5. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
[TBL] [Abstract][Full Text] [Related]
6. ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer.
Chen D; Bhat-Nakshatri P; Goswami C; Badve S; Nakshatri H
Cancer Res; 2013 Sep; 73(18):5821-33. PubMed ID: 23832666
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and pro inflammatory status in the breast tumor microenvironment.
Sanguinetti A; Santini D; Bonafè M; Taffurelli M; Avenia N
World J Surg Oncol; 2015 Mar; 13():129. PubMed ID: 25881039
[TBL] [Abstract][Full Text] [Related]
8. Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry.
Tőkés AM; Szász AM; Juhász E; Schaff Z; Harsányi L; Molnár IA; Baranyai Z; Besznyák I; Zaránd A; Salamon F; Kulka J
Pathol Oncol Res; 2012 Jul; 18(3):593-606. PubMed ID: 22193974
[TBL] [Abstract][Full Text] [Related]
9. The Role of Breast Cancer Stem Cells and Some Related Molecular Biomarkers in Metastatic and Nonmetastatic Breast Cancer.
El Abbass KA; Abdellateif MS; Gawish AM; Zekri AN; Malash I; Bahnassy AA
Clin Breast Cancer; 2020 Aug; 20(4):e373-e384. PubMed ID: 32299754
[TBL] [Abstract][Full Text] [Related]
10. Effects of differential distribution of microvessel density, possibly regulated by miR-374a, on breast cancer prognosis.
Li JY; Zhang Y; Zhang WH; Jia S; Kang Y; Tian R
Asian Pac J Cancer Prev; 2013; 14(3):1715-20. PubMed ID: 23679262
[TBL] [Abstract][Full Text] [Related]
11. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
[TBL] [Abstract][Full Text] [Related]
12. Profiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.
Ghebeh H; Sleiman GM; Manogaran PS; Al-Mazrou A; Barhoush E; Al-Mohanna FH; Tulbah A; Al-Faqeeh K; Adra CN
BMC Cancer; 2013 Jun; 13():289. PubMed ID: 23768049
[TBL] [Abstract][Full Text] [Related]
13. Correlation of breast cancer axillary lymph node metastases with stem cell mutations.
Donovan CA; Pommier RF; Schillace R; O'Neill S; Muller P; Alabran JL; Hansen JE; Murphy JA; Naik AM; Vetto JT; Pommier SJ
JAMA Surg; 2013 Sep; 148(9):873-8. PubMed ID: 23884447
[TBL] [Abstract][Full Text] [Related]
14. Distinct breast cancer stem/progenitor cell populations require either HIF1α or loss of PHD3 to expand under hypoxic conditions.
Iriondo O; Rábano M; Domenici G; Carlevaris O; López-Ruiz JA; Zabalza I; Berra E; Vivanco Md
Oncotarget; 2015 Oct; 6(31):31721-39. PubMed ID: 26372732
[TBL] [Abstract][Full Text] [Related]
15. Expression of cGMP-dependent protein kinase, PKGIα, PKGIβ, and PKGII in malignant and benign breast tumors.
Karami-Tehrani F; Fallahian F; Atri M
Tumour Biol; 2012 Dec; 33(6):1927-32. PubMed ID: 22791569
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions.
Lopes N; Sousa B; Martins D; Gomes M; Vieira D; Veronese LA; Milanezi F; Paredes J; Costa JL; Schmitt F
BMC Cancer; 2010 Sep; 10():483. PubMed ID: 20831823
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of Breast Ducts in Normal-Risk and High-risk Women and Their Relationship to Ductal Cytologic Atypia.
Danforth DN; Filie AC; Warner AC; Wright GW; Sun Z; Ried T; McGowan CT; Prindiville SA
Cancer Prev Res (Phila); 2020 Dec; 13(12):1027-1036. PubMed ID: 32753377
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of CD44
Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
[TBL] [Abstract][Full Text] [Related]
19. HOXD10 expression in human breast cancer.
Vardhini NV; Rao PJ; Murthy PB; Sudhakar G
Tumour Biol; 2014 Nov; 35(11):10855-60. PubMed ID: 25081374
[TBL] [Abstract][Full Text] [Related]
20. Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.
Hawthorn L; Luce J; Stein L; Rothschild J
BMC Cancer; 2010 Aug; 10():460. PubMed ID: 20799942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
